PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-326

  1. 179 Posts.
    lightbulb Created with Sketch. 133
    I believe the peer reviews are done / almost done and being vetted for publications. so still 3-6 months to worst case 9 months away for publications. agree it's an important step.

    I assume the fda / tga etc will get a copy pre publication
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.